ScholarIQanswers from OpenAlex

Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease

PaperCitations, authors & open-access status

Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease have?

ScholarIQcitation count

Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease has 506 citations in the OpenAlex counts ScholarIQ stores.

When was Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease published?

ScholarIQyear

Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease has 2006 year in the ScholarIQ index.

What is the open-access status of Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease?

ScholarIQoa status

Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease has bronze oa status in the ScholarIQ index.

What is the DOI of Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease?

ScholarIQdoi

The DOI for Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease is on the source record.

What is the PMID of Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease?

ScholarIQpmid

The PMID for Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease is on the source record.

What is the OpenAlex record for Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease?

ScholarIQopenalex

The OpenAlex for Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial